In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

Exercise training leads to an increase of the proangiogenic TIE2 monocyte/ EPC ratio in patients with peripheral arterial disease over 6 months

Session Poster session 3

Speaker Joern Fredrik Dopheide

Event : ESC Congress 2015

  • Topic : preventive cardiology
  • Sub-topic : Exercise Testing
  • Session type : Poster Session

Authors : J F Dopheide (Mainz,DE), J Rubrech (Mainz,DE), A Trumpp (Mainz,DE), P Geissler (Mainz,DE), T Gori (Mainz,DE), M P Radsak (Mainz,DE), T Muenzel (Mainz,DE), C Espinola-Klein (Mainz,DE)

Authors:
J.F. Dopheide1 , J. Rubrech1 , A. Trumpp1 , P. Geissler1 , T. Gori1 , M.P. Radsak1 , T. Muenzel1 , C. Espinola-Klein1 , 1University Hospital of Mainz - Mainz - Germany ,

Citation:
European Heart Journal ( 2015 ) 36 ( Abstract Supplement ), 460

Background: Tie2+ monocytes (TEM) and endothelial progenitor cells (EPC) play a crucial role in neoangiogenesis. In peripheral arterial disease (PAD) exercise training can promote angiogenesis and thus ameliorate the severity of the disease.

Methods: 40 PAD patients with intermittent claudicatio (IC, Fontaine State II a and b) were asked to perform either a supervised (SET (n=20)) or a non-supervised exercise training (NET (n=20)). Peripheral blood leukocytes were analysed from whole blood by flow cytometry (Beckman-Coulter Navios 10/3). Monocytes and EPC were identified by different gating strategies in relation to size and granulation (FSC/ SSC) and surface molecules (CD14/CD86/CD45/CD34) and analysed for CD14/CD16/Tie2 or CD34+/VEGF-R2+/CD45-, respectively. The results were compared with an age matched control group (n=20).

Results: At admission patients in total showed an increased proportion of EPC and reduced proportion of TEM (both p<0.001) in comparison to controls, leading to a TEM/ EPC ratio in favour of EPC (p<0.0001). After 6 months training, we observed a decrease in EPC proportion for patients (p<0.01) with a shift of the TEM/ EPC ratio in favour of TEM (p<0.01), leading to no difference between patients and controls in regard to EPC and their ratio. TEM proportions though were still lower for patients (p<0.05). Comparison of SET vs. NET showed a higher proportion of TEM for the SET group, and thus an increased TEM/ EPC ratio (both p<0.05). The absolute walking distance in the SET group was higher than in NET (725±457 m vs. 545±192 m) though not significant (p=0.92).

Conclusions: Exercise training can influence the distribution of proangiogenic cells. The depletion of EPC from the circulatory pool might be related to a potentially increased collateral growth, leading to a shift of the TEM/EPC ratio in favour of TEMs. SET seems to be more effective in regard to TEM than NET. Thus, the TEM/ EPC ratio might be used as a helpful tool to monitor the effectiveness of any type of exercise training.

The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are